Document:

Unassociated Document

Exhibit
4.4

 

The
following schedule identifies the material details of certain options to
purchase an aggregate of 138,951 shares of its common stock issued by the
Registrant as of December 1, 2004, all of which options are in substantially the
form attached as Exhibit 4.3 to the Registrant’s Annual Report on Form 10-KSB
for the year ended December 31, 2004. 

 

	Holder
	 	 	
      Shares
	 
	Yale
      University
	 	 	
      12,691
	 
	Yale
      University
	 	 	
      79,951
	 
	The
      Research Foundation of the State University of New York
	 	 	
      8,460
	 
	Thomas
      Bardos
	 	 	
      1,410
	 
	Chien-Neng
      Chang
	 	 	
      2,056
	 
	Yung-Chi
      Cheng
	 	 	
      32,209
	 
	Yung-Chi
      Cheng
	 	 	
      1,410
	 
	Simon
      M.N. Efange
	 	 	
      1,410
	 
	Alan
      C. Schroeder
	 	 	
      1,410Exhibit
10.11

AMENDMENT
NO. 1 TO 

EMPLOYMENT
AGREEMENT

 

 

THIS
AMENDMENT NO. 1 (the “Amendment”) to the EMPLOYMENT AGREEMENT (the “Agreement”),
is made as of October 21, 2004 by and between Hana Biosciences, Inc. (formerly
Hudson Health Sciences, Inc.), a Delaware corporation (the “Company”), and Mark
J. Ahn (“Executive”).

 

WHEREAS,
the parties hereto entered into that certain Employment Agreement dated November
1, 2003 (the “Agreement”); and

 

WHEREAS,
the parties desire to amend Section 5(f)(ii) of the Agreement in order to
clarify the agreement of the parties with respect to the terms of certain
additional Stock Options to be granted to Executive.

 

NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants and agreements hereinafter
set forth, the Company and Executive agree as follows:

 

1. As of the
date hereof, subparagraph (f)(ii) of Section 5 shall be amended and restated in
its entirety as follows:

 

“(ii) Anti-dilution
Protection. Until
such time as the Company has raised gross proceeds equal to $10,000,000 through
the sale of its equity securities, the Company shall issue to the Executive a
number of additional Stock Options sufficient to maintain Executive’s ownership
percentage at eight percent (8%). Thereafter, and until the Company has raised
gross proceeds equal to $50,000,000 through the sale of equity securities, the
Company shall issue to the Executive a number of additional Stock Options
sufficient to maintain Executive’s ownership percentage at or greater than five
percent (5%). Once the Company has raised $50,000,000 through the sale of its
equity securities, Executive shall be diluted pro rata along with all other
holders of securities of the Company. With respect to any additional Stock
Options granted pursuant to this subparagraph (ii), such options shall (A) vest
in three equal annual installments commencing on the date the Company’s
obligation to issue such additional Stock Options is triggered, and (B) have an
exercise price equal to the greater of (x) the exercise price applicable to the
Stock Options granted to Executive in accordance with subparagraph (i), as
adjusted for stock splits, combinations, recapitalizations, mergers and the
like, and (y) twenty percent (20%) of the closing sale price of the Company’s
common stock on the day the Company’s obligation to issue such additional Stock
Options is triggered. The Company’s obligation to issue such additional Stock
Options shall be deemed triggered on the last day of any fiscal quarter in which
the Company issued additional shares of its common stock that resulted in
Executive’s ownership percentage decreasing below 8 or 5 percent (as
applicable); provided,
however, that if
the Company completes a financing transaction involving the sale of the
Company’s equity securities, then the obligation shall be deemed triggered as of
the date of closing of such financing.”

2. The
parties hereby acknowledge and agree that Executive is entitled to and has been
granted the additional Stock Options described on Schedule
A attached
hereto and that such options fully satisfy the Company’s obligation under
Section 5(f)(ii) as of the date of this Amendment. The parties further
acknowledge and agree that, as of the date of this Amendment, the Company has
raised $12,721,134.25 through the sale of its equity securities.

3. All
capitalized terms used but not defined herein shall have the meanings ascribed
to them in the Agreement.

4. Except as
amended or modified by this Amendment, the parties hereby confirm all other
terms and provisions of the Agreement.

5. This
Amendment may be executed in any number of counterparts, each of which shall
constitute an original, but all of which together shall constitute one and the
same instrument.

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date
first above written.

	COMPANY:	 	EXECUTIVE:	 
	 	 		 
	Hana Biosciences, Inc.	 	 	 
		 	
       
	 
	By:          /s/
      Fred Vitale          
      	 	 	 
	    Its: Vice
      President	 	          /s/ Mark
      J. Ahn          
      	 
	 	 	           
      Mark
      J. AhnNEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF
THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 ( THE "ACT"),
AND NEITHER THIS WARRANT NOR SUCH SHARES MAY BE SOLD, ENCUMBERED OR OTHERWISE
TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH
ACT OR AN EXEMPTION FROM SUCH REGISTRATION REQUIREMENT, AND, IF AN EXEMPTION
SHALL BE APPLICABLE, THE HOLDER SHALL HAVE DELIVERED AN OPINION OF COUNSEL
REASONABLY ACCEPTABLE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

Void after 5:00 P.M. New YORK CITY time on the seventh anniversary of the date
hereof.

                        WARRANT TO PURCHASE COMMON STOCK
                                       OF
                           MARLTON TECHNOLOGIES, INC.

This is to certify that, FOR VALUE RECEIVED, ARGOSY INVESTMENT PARTNERS II, L.P.
("ARGOSY") is entitled to purchase, subject to the provisions of this Warrant to
Purchase Common Stock (the "WARRANT"), from MARLTON TECHNOLOGIES, INC., a
Pennsylvania corporation (the "COMPANY"), at an exercise price of Ninety-Eight
Cents($.98) per share, Three Hundred Twenty-One Thousand Four Hundred Thirty
(321,430) shares of Common Stock, without par value, of the Company (the "COMMON
STOCK") at any time during the period (the "EXERCISE PERIOD") commencing as of
the date hereof, and ending at 5:00 p.m. New York City time, on the seventh
anniversary of the date hereof. The number of shares of Common Stock to be
received upon the exercise of this Warrant and the price to be paid for a share
of Common Stock also may be adjusted from time to time as hereinafter set forth.
The shares of Common Stock deliverable upon such exercise, and as adjusted from
time to time, are hereinafter sometimes referred to as "WARRANT SHARES," and the
exercise price for the purchase of a share of Common Stock pursuant to this
Warrant in effect at any time and as adjusted from time to time is hereby
referred to as the "EXERCISE PRICE". This Warrant is one of the warrants issued
pursuant to the agreement (the "SHOWTIME AGREEMENT") dated as of March 15, 2005
to which the Company and the above-named holder are parties pursuant to which an
aggregate of up to 600,000 shares (subject to adjustment as provided herein) of
Common Stock may be issued. References to all of the Warrants shall include all
outstanding Warrants to Purchase Common Stock of the Company originally issued
pursuant to the Showtime Agreement, including Warrants held by transferees.

<PAGE>

      1. EXERCISE OF WARRANT.

            (a) Except as otherwise provided for herein, this Warrant may be
exercised in whole at any time, or in part from time to time, during the
Exercise Period by presentation and surrender hereof to the Company at its
principal office, or at the office of its stock transfer agent, if any, with the
Purchase Form annexed hereto as Exhibit A duly executed and by paying in full,
in lawful money of the United States, in cash, certified check or bank draft
payable to the order of the Company, the Exercise Price for each full share of
Common Stock as to which the Warrant is exercised and any and all applicable
taxes due in connection with the exercise of the Warrant, the exchange of the
Warrant for the Common Stock, and the issuance of the Common Stock. If this
Warrant should be exercised in part only, the Company shall, upon surrender of
this Warrant for cancellation, execute and deliver a new Warrant evidencing the
rights of the Holder hereof to purchase the balance of the shares purchasable
hereunder. Upon receipt by the Company of this Warrant and the Exercise Price
therefor at its office, or by the stock transfer agent of the Company at its
office, in proper form for exercise, the Registered Holder (as defined) shall be
deemed to be the holder of record of the shares of Common Stock issuable upon
such exercise provided, that if the date of such surrender and payment is a date
when the stock transfer books of the Company are closed, such person shall be
deemed to have become the Registered Holder of such shares at the close of
business on the next succeeding date on which the stock transfer books are open.

            (b) In the event the Warrant Shares shall not have been registered
under the Act pursuant to Section 10 or otherwise at the time when the Holder
elects to exercise this Warrant and the Warrant Shares sought to be acquired
cannot be registered under the Act within twenty (20) days (as determined in the
reasonable commercial judgment of the Company in consultation with its counsel
and counsel to the Holder) after the Company's receipt of written notice from
the Holder of its desire to obtain Warrant Shares as provided in this Subsection
1(b), in addition to the rights of the Holder under the preceding provisions of
Subsection 1(a), the Holder shall have the right, in lieu of paying the Exercise
Price in cash, to instruct the Company to reduce the number of shares of Common
Stock thereafter eligible to be purchased by such holder pursuant to Warrants
held by it in accordance with the following formula:

                                          P
                           N =      -------------
                                      ( M - E )

where:

      N =    the number of shares of Common Stock to be subtracted from
             remaining number of Warrant Shares purchasable upon exercise of
             such holder's Warrants; and

      P =    the aggregate Exercise Price otherwise payable for the shares
             issuable upon exercise of the Warrants; and

                                       2
<PAGE>

      M =    the Market Price Per Share (as defined in Section 4(b)), determined
             as of the date of such exercise; and

      E =    the Exercise Price on the date of such exercise.

      2. VALID ISSUANCE. All shares of Common Stock issued upon the proper
exercise of this Warrant in conformity with the terms
hereof shall be validly issued, fully paid and non-assessable.

      3. RESERVATION OF COMMON STOCK; LISTING OF SHARES. The Company hereby
agrees that: (a) at all times there shall be reserved for issuance and/or
delivery upon exercise of this Warrant such number of shares of its Common Stock
as shall be required for issuance and delivery upon exercise of this Warrant;
and (b) in the event the shares of the Company's Common Stock are included on
American Stock Exchange or another national securities exchange, it shall cause
the Warrant Shares to be so listed.

      4. FRACTIONAL SHARES.

            (a) The Company shall not be required to issue fractional shares
upon exercise of this Warrant. If upon exercise of this Warrant the Company
would be required to issue a fractional number of shares, the Company shall, in
lieu thereof, pay to the Registered Holder an amount in cash equal to such
fraction multiplied by the current Market Price Per Share (as defined), as of
the last business day prior to the date of exercise of this Warrant.

            (b) As used herein, the term "MARKET PRICE PER SHARE" on any date
shall mean the average closing price per share of the Common Stock for the ten
(10) trading days immediately preceding such date. The closing price for each
such day shall be the last sale price or, in case no such sale takes place on
such day, the average of the closing bid and asked prices, in either case on the
principal securities exchange (including any automated system of quotation) (an
"EXCHANGE") on which the Common Stock is listed or admitted for trading, or, if
not so listed on an Exchange, the average of the closing bid and asked prices as
furnished by two members of the National Association of Securities Dealers, Inc.
selected from time to time by the Company for that purpose. If such bid and
asked prices are not available, then "Market Price Per Share" shall be the fair
market value of the Company's Common Stock as determined in good faith by the
Board of Directors of the Company.

      5. EXCHANGE, TRANSFER, ASSIGNMENT OR LOSS OF WARRANT. This Warrant is
exchangeable, without expense, at the option of the Registered Holder, upon
presentation and surrender hereof to the Company or at the office of its stock
transfer agent, if any, for other warrants of different denominations entitling
the Registered Holder thereof to purchase in the aggregate the same number of
shares of Common Stock purchasable hereunder. Subject to the provisions of

                                       3
<PAGE>

Section 9 of this Warrant, upon surrender of this Warrant to the Company or at
the office of its stock transfer agent, if any, with funds sufficient to pay any
transfer tax, the Company shall, without charge, execute and deliver a new
Warrant in the name of the assignee named in such instrument of assignment and
this Warrant shall promptly be canceled. This Warrant may be divided or combined
with other Warrants which carry the same rights upon presentation hereof at the
office of the Company or at the office of its stock transfer agent, if any,
together with a written notice specifying the names and denominations in which
new Warrants are to be issued and signed by the Registered Holder hereof. The
term "WARRANT" as used herein includes any Warrants into which this Warrant may
be divided or exchanged. Upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this
Warrant, and (in the case of loss, theft or destruction) of reasonably
satisfactory indemnification, and upon surrender and cancellation of this
Warrant, if mutilated, the Company will execute and deliver a new Warrant of
like tenor and date.

      6. RIGHTS OF THE HOLDER. The holder of this Warrant shall not, by virtue
of this Warrant, be entitled to any rights of a stockholder in the Company,
either at law or equity, and the rights of the holder of this Warrant are
limited to those expressed in this Warrant and are not enforceable against the
Company except to the extent set forth herein.

      7. ANTIDILUTION ADJUSTMENT OF NUMBER OF WARRANT SHARES AND EXERCISE PRICE;
OTHER RECLASSIFICATIONS, REORGANIZATIONS OR MERGERS.

            (a) In case the Company shall (i) pay a dividend or make a
distribution on its shares of Common Stock in shares of Common Stock, (ii)
split, subdivide or reclassify its outstanding Common Stock into a greater
number of shares or (iii) combine or reclassify its outstanding Common Stock
into a smaller number of shares, then the number of Warrant Shares issuable upon
exercise of this Warrant, and the Exercise Price per share in effect at the time
of the record date for such dividend or distribution or at the effective date of
such split, subdivision, combination or reclassification, shall be
proportionately adjusted so that if this Warrant is exercised after such date,
the Registered Holder shall be entitled to receive for the same aggregate
purchase price, the aggregate number and kind of shares which, if this Warrant
had been exercised immediately prior to such time, such Holder would have owned
after giving effect to such dividend or distribution, split, subdivision,
combination or reclassification. Such adjustments shall be made successively
whenever any event listed in this Section 7 shall occur. All price calculations
under this Section 7 shall be made to the nearest whole cent and share
adjustments to the nearest whole share.

            (b) If after the date hereof any capital reorganization or
reclassification of the Common Stock of the Company, or consolidation or merger
of the Company with or into another corporation, or the sale of all or
substantially all of its assets to another corporation or other similar event
(collectively referred to as a "TRANSACTION") shall be effected, then, as a

                                       4
<PAGE>

condition of such Transaction, lawful and fair provision shall be made whereby
the Registered Holder of this Warrant shall thereafter have the right by
exercising this Warrant, to purchase (in lieu of purchasing the shares of Common
Stock of the Company immediately theretofore purchasable and receivable upon the
exercise of this Warrant), the kind and amount of shares of stock, securities,
or assets receivable upon such Transaction by a holder of the number of shares
of Common Stock which might have been purchased upon exercise of this Warrant
immediately prior to such Transaction. In such event, appropriate provision
shall be made with respect to the rights and interests of the Registered Holder
of this Warrant to the end that the provisions hereof (including, without
limitation, provisions for adjustments of the Exercise Price and of the number
of shares purchasable upon the exercise of this Warrant) shall thereafter be
applicable, as nearly as may be, to any share of stock, securities, or assets
thereafter deliverable upon the exercise hereof. The Company shall not effect
any such Transaction unless prior to the consummation thereof the successor
corporation (if other than the Company) resulting from such Transaction, or the
corporation purchasing such assets, shall assume the obligations to deliver to
the Registered Holder of this Warrant such shares of stock, securities, or
assets which, in accordance with the foregoing provisions, such holder may be
entitled to purchase.

      8. NOTICES OF CHANGE IN WARRANT. Upon every adjustment of the Exercise
Price or the number of shares issuable on exercise of this Warrant, the Company
shall give written notice thereof to the Registered Holder of this Warrant,
which notice shall state the Exercise Price resulting from such adjustment and
the increase or decrease, if any, in the number of shares purchasable at such
price upon the exercise of a Warrant, setting forth in reasonable detail the
method of calculation and the facts upon which such calculation is based. Upon
the occurrence of any event specified in Section 7, then, in any such event, the
Company shall give written notice to the Registered Holder of this Warrant of
the record date for such dividend, distribution, split, reclassification or
recombination, or the effective date of Transaction. Such notice shall also
specify the date as of which the holders of Common Stock of record shall
participate in such dividend, distribution, split, reclassification or
recombination, or shall be entitled to exchange their Common Stock for stock,
securities, or other assets deliverable upon a Transaction. Failure to give such
notice, or any defect therein, shall not affect the legality or validity of such
event.

      9. COMPLIANCE WITH THE SECURITIES ACT OF 1933.

            (a) This Warrant or the Warrant Shares or any other security issued
or issuable upon exercise of this Warrant may not be sold or otherwise disposed
of except as follows:

                  (i) the holder of the Warrant or the Warrant Shares has
delivered to the Company an opinion of counsel, which opinion is reasonably
acceptable to the Company, that the transfer is exempt from the registration
requirement of the Act and the proposed transferee has delivered to the Company
an agreement to comply with the obligations of the holder of this Warrant which
agreement shall be reasonably satisfactory in form and substance to the Company;
or

                                       5
<PAGE>

                  (ii) to any person upon delivery of a prospectus then meeting
the requirements of the Act relating to such securities and the offering thereof
for such sale or disposition.

            (b) Notwithstanding anything to the contrary herein, the Company
shall not be obligated to deliver any securities issuable on exercise of this
Warrant unless the issuance of such securities has been registered under the Act
or, in the opinion of counsel to the Company, the issuance is exempt from the
registration requirements of the Act and applicable state securities laws. This
Warrant may not be exercised by, nor may any securities be issued to, any
Registered Holder in any state in which such exercise would be unlawful.

      10. "Piggyback" Registration.

      If at any time after the date hereof the Company determines to register
under the Act (including pursuant to a demand of any security holder of the
Company exercising registration rights) any of its Common Stock (except shares
to be registered on any registration form that does not permit secondary sales),
it shall give to the Holder written notice of such determination at least thirty
(30) days prior to each such filing. If, within fifteen (15) days after receipt
of such notice, the Holder so requests in writing, the Company shall include in
such registration statement (to the extent permitted by applicable regulation)
all or any part of the Holder's Common Stock purchasable or purchased from time
to time under the Holder's Warrants (the "Registrable Securities") that the
Holder requests to be registered. Any Registrable Securities which are included
in any underwritten public offering under this Section 10 will be sold upon such
terms as the managing underwriters reasonably request. In the event that any
registration pursuant to this Section 10 shall be, in whole or in part, an
underwritten public offering of Common Stock, the number of Registrable
Securities to be included in such an underwriting may be reduced (pro rata among
the requesting holders based upon the number of shares of Registrable Securities
owned by such holders) if and to the extent that the managing underwriter
provides a written opinion that such inclusion would materially and adversely
affect the marketing of the securities to be sold by the Company therein
provided, however, that such number of shares of Registrable Securities shall
not be reduced below the Holder's pro rata amount of the total number of shares
of Common Stock to be included in such underwriting for the account of any
person other than the Company or requesting holders of Registrable Securities.
If the requesting Holder disapproves of the terms of such underwriting, such
Holder may elect to withdraw therefrom by written notice to the Company and the
underwriter. The provisions of this Section 10 shall not apply to any securities
(x) theretofore effectively registered under the Act, (y) distributed to the
public pursuant to Rule 144 (or any similar provisions then in force) or (z)
covered by an opinion reasonably satisfactory in form and substance to the
Holder desiring to sell securities that the registration thereof is not
necessary to permit such sale in the manner intended (in connection with which
opinion the Holder shall furnish such information reasonably requested by such
counsel). Notwithstanding the foregoing provisions, the Company may withdraw any
registration statement referred to in this Section 10 without thereby incurring
any liability to the Holder of Registrable Securities.

                                       6
<PAGE>

      11. MISCELLANEOUS.

            (a) All communications provided for herein shall be sent, except as
may be otherwise specifically provided, by registered or certified mail: if to
the Registered Holder of this Warrant, to the address shown on the books of the
Company; and if to the Company, to Marlton Technologies, Inc., 2828 Charter
Road, Philadelphia, PA 19154, Attention: President, or to such other address as
the Company may advise the Registered Holder of this Warrant in writing. Notices
shall be deemed given when mailed.

            (b) The provisions of this Warrant shall in all respects be
constructed according to, and the rights and liabilities of the parties hereto
shall in all respects be governed by, the laws of the State of Pennsylvania,
without regard to such state's choice of law rules.

            (c) The Company shall maintain books ("WARRANT REGISTER") for the
registration of original issuance and the registration of transfer of the
Warrants. Upon the initial issuance of the Warrants, the Company shall issue and
register the Warrants in the names of the holders thereof.

            (d) Prior to due presentment for registration of transfer of this
Warrant, the Company may deem and treat the person in whose name this Warrant
shall be registered upon the Warrant Register ("REGISTERED HOLDER"), as the
absolute owner of such Warrant and of each Warrant represented thereby
(notwithstanding any notation of ownership or other writing on the Warrant
certificate made by anyone other than the Company, for the purpose of any
exercise thereof, and for all other purposes, and the Company shall not be
affected by any notice to the contrary).

Dated: March ___, 2005

                                         MARLTON TECHNOLOGIES, INC.

                                         By:
                                            --------------------------
                                            Robert Ginsburg, President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00081-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00081-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00081-of-00352.parquet"}]]